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RNA virusesWe performed experiments to determine the effect of PKR activation on respiratory syncytial virus (RSV)
replication. We ﬁrst determined that RSV infection activates PKR which induces the phosphorylation of eIF2α,
resulting in the formation of host stress granules. We used RNA interference to decrease endogenous PKR
levels. RSV replication was not altered in cells deﬁcient for PKR expression. However, RSV-mediated stress
granule formation was signiﬁcantly reduced in PKR-knockdown cells. As an alternative method to block PKR
activation, we used treatment with the kinase inhibitor 2-aminopurine (2-AP). We observed that 2-AP
treatment signiﬁcantly reduced viral replication. We also treated PKR-knockdown cells with 2-AP and
inoculated with RSV. Under these conditions, 2-AP treatment diminished viral replication in the absence of
PKR expression. These results suggest that PKR activation has a minimal effect on RSV replication and that the
antiviral effect of 2-AP during RSV infection likely occurs via a PKR-independent mechanism.edical Center, T2220 Medical
7232-2905, USA. Fax: +1 615
owe).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Respiratory syncytial virus (RSV) infection is a leading cause of
serious viral lower respiratory tract illness in both infants and the
elderly worldwide. RSV is a member of the Paramyxoviridae family and
belongs to the Pneumovirinae subfamily. The RSV genome consists of a
single-stranded, negative-senseRNAmolecule that encodes11proteins.
The viral nucleoprotein (N), phosphoprotein (P), and the large
polymerase protein (L) make up the ribonucleoprotein complex that
is necessary for viral transcription and replication. Each of these
replication complex proteins is found, along with genomic viral RNA,
in discrete cytoplasmic granules often termed viral inclusion bodies
(Garcia et al., 1993; Carromeu et al., 2007; Lindquist et al., 2010). These
inclusion bodies are thought to represent sites of viral replication.While
transcription of viral proteins likely occurs immediately after entry into
host cells, detectable replication of the viral genome appears to begin
several hours after inoculation. Following accumulation of sufﬁcient
amounts of viral proteins, a transition occurs in the RSV replication
program from one dominated by transcription of viral genes to one in
which replication of the full-length genomepredominates. As is the case
for all negative-sense single-stranded RNA viruses, for replication tooccur, the virus must ﬁrst make a full-length antigenome intermediate
RNA, which then serves as template for the production of new RNA
genomes (Cowton et al., 2006).
PKR is activated by double-stranded RNA (dsRNA) during viral
infection and often is associatedwith antiviral host cell responses. Upon
binding to dsRNA, PKR dimerizes and is autophosphorylated, resulting
in activationof theprotein. PhosphorylatedPKR is oneof the four known
kinases that regulates the activation of the translation initiation factor
eukaryotic initiation factor 2 (eIF2α), which also include PKR-like
ER-localized eIF2α kinase (PERK), heme-regulated inhibitor (HRI)
kinase, and general control nonrepressed 2 (GCN2) kinase. Upon
binding to eIF2α, activated PKR phosphorylates eIF2α at serine 51.
Phosphorylated eIF2α is incapable of delivering initiator Met-tRNA to
host translation complexes, resulting in a reduction of protein synthesis
in virus-infected cells. eIF2αphosphorylation also leads to the formation
of host stress granules, which are host RNA cytoplasmic granules that
contain mRNA, translation factors, and mRNA-binding proteins. In
addition to activating eIF2α, PKR also functions in the activation of
other proteins such as STAT1, p53, and NFκB (Garcia et al., 2007).
Many viruses deploy mechanisms to prevent PKR activation,
presumably to inhibit the type I interferon response or to ensure that
the host translation machinery remains sufﬁciently active for viral
protein synthesis. Viral strategies to prevent PKR activation include
expression of viral products that interact directly with PKR and
prevent activation, expression of viral proteins that bind and
sequester dsRNA, or activation of host proteins that inhibit or
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studied to date, the activation of PKR in virus-infected cells is
associated with induction of an antiviral state. However, activation of
PKR during hepatitis C virus (HCV) infection may enhance viral
replication because of the resulting lack of synthesis of speciﬁc
antiviral interferon-stimulated gene products during infection (Gar-
aigorta and Chisari, 2009).
RSV infection leads to increased levels of total PKR in cells during
infection (Groskreutz et al., 2006). RSV infection also can induce the
phosphorylation and activation of PKR (Groskreutz et al., 2010). These
studies suggest a direct interaction between PKR and the RSV
nucleoprotein (N).
In the current study, we sought to determine the functional role
of PKR expression and activation in response to RSV infection using
two well-established methods of PKR inhibition. The data revealFig. 1. PKR and eIF2α are phosphorylated during RSV infection. (A) HEp-2 cells were inf
immunoﬂuorescence. Anti-RSV Pmonoclonal antibody was used to localize viral protein and
formation and appears red in the merge panel. Phosphorylated eIF2α (peIF2α) appears bl
(MOI=1.0 pfu/cell) for 24 h. Cell lysates were analyzed by immunoblots for GAPDH, RSV P, p
to mock-infected cells were quantiﬁed using Li-Cor Odyssey imaging software.that 2-aminopurine (2-AP), a previously deﬁned PKR chemical
inhibitor, reduced RSV replication. Unexpectedly PKR protein
knockdown by shRNA did not affect RSV replication. However, we
did observe a drastic decrease in stress granule formation in PKR-
knockdown cells. These results suggest that PKR expression and
activation have little effect on RSV replication in cultured cells, and
that the PKR inhibitor 2-AP likely inhibits RSV replication in a
manner independent of PKR.
Results
RSV induces the activation of PKR and eIF2α
RSV infection potently induces stress granule formation (Lindquist
et al., 2010). We sought here to determine the mechanism by whichected with RSV (MOI=1.0 pfu/cell) for the indicated times, ﬁxed, and processed for
appears green in themerge panel. Anti-TIA-1 antibody was used to detect stress granule
ue in the merge panel. (B) HEp-2 cells were mock-inoculated or inoculated with RSV
hosphorylated PKR, or total PKR. Relative protein densities comparing RSV-infected cells
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induction of one of many types of stress-related pathways that result
in a common downstream event, phosphorylation of the translation
initiation factor, eIF2α (Kedersha and Anderson, 2007). Therefore, we
examined cells inoculated with RSV (MOI=1.0 pfu/cell) for the
presence of phosphorylated eIF2α using indirect immunoﬂuores-
cence. We observed a striking increase in eIF2α phosphorylation
beginning 12 h post-inoculation that was concomitant with the
appearance of stress granules and continued throughout infection
(Fig. 1A).
We next sought to determine the mechanism by which RSV
mediates the phosphorylation of eIF2α. There are four well-deﬁned
kinases capable of eIF2α phosphorylation: protein kinase RNA (PKR),
a kinase activated by double-stranded RNA; PKR-like ER-localized
eIF2α kinase (PERK); general control nonrepressed 2 (GCN2); and
heme-regulated inhibitor kinase (HRI) (Proud, 2005). We reasoned
that PKR was likely responsible for eIF2α phosphorylation during RSV
infection, as it is known that RSV infection activates PKR (Groskreutz
et al., 2010). In cells inoculated with RSV (MOI=1.0 pfu/cell) for 24 h,
we observed phosphorylated PKR and higher expression of total PKR
in comparison to mock-inoculated cells (Fig. 1B), consistent with
previous reports.
Knockdown of PKR expression does not affect RSV replication
We investigated what effects inhibition of PKR signaling might
have on RSV replication. HEp-2 cells were transduced with shRNA
lentiviral constructs speciﬁc for PKR or a non-targeting shRNA control.
We selected for cells stably expressing the shRNA constructs and we
compared PKR levels by immunoblotting in wild-type cells that were
not transduced or cells transduced with PKR-targeting or non-
targeting shRNA. Cells expressing the PKR shRNA construct exhibited
an approximate 90% decrease in total PKR protein levels (Fig. 2A) in
comparison to wild-type cells or those expressing a non-targeting
shRNA. Wild-type, non-targeting, or PKR-knockdown cells were
inoculated with RSV (MOI=1.0 pfu/cell) and incubated for 24 h.Fig. 2. PKR knockdown does not affect RSV replication. (A) Wild-type HEp-2 cells or
HEp-2 cells transduced with non-targeting shRNA (NonT) or PKR-speciﬁc shRNA were
mock-inoculated or inoculated with RSV (MOI=1.0 pfu/cell) for 24 h. Cell lysates were
analyzed by immunoblotting for total PKR, phosphorylated PKR, or GAPDH. (B) Each
cell type from (A) was inoculated with RSV (MOI=0.1 pfu/cell) for the indicated times.
Titers of cell-associated virus were determined for each time point by plaque assay.
Error bars indicate standard deviations.Immunoblot analysis of cell lysates did not demonstrate an increase in
PKR phosphorylation in the RSV-inoculated PKR-knockdown cells in
comparison to wild-type or non-targeting shRNA cells. We next
quantiﬁed the viral titers over a time course for each cell type. Cells
were inoculated with RSV (MOI=0.1 pfu/cell) and incubated for 0–
4 days. Cell-associated virus was harvested for each time point, and
titers were determined by plaque assay. Viral titers in the PKR-
knockdown cells did not differ signiﬁcantly from those in either wild-
type cells or non-targeting shRNA-expressing cells (Fig. 2B). These
results indicate that inhibition of PKR activation does not affect RSV
replication.
Knockdown of PKR prevents formation of RSV-induced stress granules
during infection
We next determined whether PKR is the kinase responsible for
stress granule formation during RSV infection. We infected wild-type,
shRNA non-targeting, or PKR-knockdown cells with RSV for 48
h (MOI=5.0 pfu/cell). We then examined cells for the presence of
stress granules using indirect immunoﬂuorescence (Fig. 3A). In wild-
type and shRNA non-targeting cells, we observed robust stress
granule formation in infected cells. However, in PKR-knockdown
cells, stress granule formation was substantially diminished. We
quantiﬁed the number of RSV-infected cells that formed stress
granules for each cell type. Our results show that while approximately
25–30% of infected wild-type and shRNA non-targeting cells form
stress granules, stress granules form in only 2% of infected PKR-
knockdown cells (Fig. 3B). When each cell type was treated with
sodium arsenite, a drug that induces stress granules via HRI kinase
rather than PKR, we observed an equivalent frequency of stress
granule formation (data not shown). These results conﬁrm that PKR is
required for stress granule formation following RSV infection.
The chemical inhibitor 2-AP prevents PKR signaling and reduces RSV
infection
To conﬁrm that PKR activation is dispensable for RSV replication,
we sought another method to inhibit activation of the kinase. The
nucleotide analog 2-AP prevents PKR activation (Hu and Conway,
1993). We ﬁrst tested whether 2-AP treatment alters RSV-mediated
PKR activation. HEp-2 epithelial cells were pretreated with 10 mM 2-
AP or vehicle for 2 h. We then inoculated cells with RSV (MOI=1.0
pfu/cell) in the presence of 2-AP or vehicle control for 1 h. The
inoculumwas removed and replacedwithmedium containing 2-AP or
vehicle, and the infection was allowed to proceed for 24 h. Cell lysates
were harvested for immunoblotting to assess the level of total or
phosphorylated PKR. The phosphorylation of PKR in RSV-infected cells
treated with 2-AP was greatly reduced in comparison to vehicle-
treated cells (Fig. 4A). In addition, we did not observe an increase in
total PKR levels in the presence of 2-AP that occurs during RSV
infection following virus inoculation. As a control, we compared 2-AP-
treated and vehicle-treated cells in the absence of infection and found
no changes in the levels of PKR or phosphorylated PKR. These results
indicate that 2-AP inhibits PKR activation during RSV infection. We
next assessed the effect of 2-AP treatment on viral protein expression
using an immunoblotting assay for RSV P protein as a surrogate
marker. Relative amounts of total PKR, phosphorylated PKR, RSV P,
and GAPDHwere quantiﬁed using Odyssey imaging analysis software.
Interestingly, we observed a 70% decrease in the amount of RSV P
protein in 2-AP-treated cells in comparison to vehicle-treated cells.
This result suggests that treatment with 2-AP inhibits viral protein
synthesis.
To directly determine the effect of 2-AP treatment on RSV
infection, we used indirect immunoﬂuorescence to detect viral
proteins in infected cells. Cells were pretreated with 2-AP or vehicle
and inoculated with RSV (MOI=1.0 pfu/cell). After 24 h, cells were
Fig. 3. PKR expression is necessary for RSV-induced stress granule formation. (A)Wild-type cells or HEp-2 cells transduced with non-targeting shRNA (NonT) or PKR-speciﬁc shRNA
were inoculated with RSV (MOI=5.0 pfu/cell) for 48 h, ﬁxed, and processed for immunoﬂuorescence. Anti-G3BP monoclonal antibody was used to detect stress granules and
appears green in the merge panel. Anti-RSV F antibody was used to localize viral protein and appears red in the merge panel. PKR appears blue in the merge panel. (B) For each cell
type from (A), the percentage of infected cells containing stress granules per high-powered ﬁeld (HPF) was determined. A total of 20 HPFs were counted for each cell type. Error bars
indicate SEM.
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infected cells per high-powered ﬁeld (HPF) were quantiﬁed for each
treatment. We observed an approximately 80% decrease in the
percent of cells that stained positively for RSV F protein following 2-
AP treatment (Fig. 4B and C). Thus, 2-AP treatment diminishes RSV
infectivity.
To determine the effects of 2-AP treatment on the capacity of RSV
to complete an infectious cycle, cells were pretreated with vehicle or
2-AP and inoculated with RSV (MOI=0.1 pfu/cell). After a 1-
h adsorption, the inoculum was replaced with medium containing
vehicle or 2-AP. Titers of cell-associated virus were determined at 24-
h intervals for 0–4 days. The results show that 2-AP treatment
mediated an approximately 1000-fold decrease in viral titer through-
out the time course of infection (Fig. 5A). To determine if 2-AP
treatment affects viral entry, cells were pretreatedwith 2-AP and then
inoculated with RSV (MOI=0.1 pfu/cell). The inoculum then was
replaced with medium containing vehicle control only and incubated
for 0–4 days. In contrast to cells incubated with 2-AP throughout
infection, cells that had only been pretreated with 2-AP exhibited no
change in viral titer when compared to vehicle-treated cells. These
results suggest that 2-AP does not affect viral entry but rather a later
step in the viral life cycle. To determine whether the effects of 2-AP
treatment on RSV were virus-speciﬁc, we performed a similarexperiment using reovirus. Reovirus replication is unaffected by PKR
knockdown (Zhang and Samuel, 2007). In addition, the reovirus σ3
protein inhibits PKR activation by competitively binding dsRNA
targets (Sherry, 2009). In contrast to our results with RSV, 2-AP
treatment only affected reovirus replication during the ﬁrst 24 h after
infection. After 24 h, we did not observe a signiﬁcant difference in
viral titers between 2-AP-treated or vehicle-treated cells, indicating
that 2-AP treatment is much less inhibitory for reovirus replication in
comparison to the effect on RSV (Fig. 5B).2-AP inhibits RSV replication in the absence of PKR
We next tested whether the effect on viral replication observed
following 2-AP treatment requires PKR. We quantiﬁed the effect on
viral titers in RSV-inoculated wild-type, non-targeting shRNA, or PKR-
knockdown cells treated with 2-AP or vehicle. Cells were inoculated
with RSV (MOI=0.1 pfu/cell) and incubated for 0–4 days. Cells were
collected for each time point, and titers of cell-associated virus were
determined by plaque assay. Treatment of cells with 2-AP once again
mediated a 1000-fold reduction in viral titers throughout the time
course (Fig. 6A). Remarkably, 2-AP inhibited RSV replication in each
cell type regardless of whether PKR was expressed or induced.
Fig. 4. Treatment with 2-AP prevents PKR activation during RSV infection. (A) HEp-2
cells were pretreated with 10 mM 2-AP or vehicle. Cells then were mock-inoculated or
inoculated with RSV (MOI=1.0 pfu/cell) for 24 h in the presence of 2-AP or vehicle. Cell
lysates were analyzed by immunoblots for GAPDH, RSV P, phosphorylated PKR, or total
PKR. Relative protein densities were quantiﬁed using Li-Cor Odyssey imaging software.
The relative amount of RSV P protein expression was quantiﬁed for cells infected with
RSV and treated with either vehicle or 2-AP. Protein levels were standardized to RSV-
infected and vehicle-treated cells. The relative expression of PKR and phosphorylated
PKR were quantiﬁed for each condition and compared to that of mock-infected cells
treated with vehicle. (B) HEp-2 cells were pretreated with 2-AP or vehicle, inoculated
with RSV (MOI=1.0 pfu/cell) for 24 h in the presence of 2-AP or vehicle, and processed
for immunoﬂuorescence. Anti-RSV F antibody was used to detect virus-infected cells.
Differential interference contrast (DIC) was used to deﬁne the periphery of each cell.
(C) The percentage of cells per HPF that stained positively for RSV F protein in images
from (B) was determined. Error bars indicate SEM.
Fig. 5. Treatment with 2-AP inhibits RSV replication. (A) HEp-2 cells were (i) pretreated
with vehicle, inoculated with RSV (MOI=0.1 pfu/cell), and incubated in medium
containing vehicle; (ii) pretreated with 2-AP, inoculated, and incubated in medium
containing vehicle; or (iii) pretreated with 2-AP, inoculated, and incubated in medium
containing 2-AP. (B) HEp-2 cells were incubated with vehicle or 2-AP and inoculated
with reovirus (MOI=5.0 pfu/cell), in the presence of 2-AP or vehicle. Viral titers were
determined at the intervals shown by plaque assay for (A) and (B). Error bars indicate
standard deviations.
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down cells with 2-AP or vehicle and inoculated the cells with RSV
(MOI=1.0 pfu/cell). Following incubation for 24 h, we harvested the
cell lysates and used immunoblots to detect total PKR, phosphorylatedPKR, or RSV P. The results show that 2-AP inhibited RSV P production
in each cell type, independent of PKR levels (Fig. 6B). Taken together,
these data indicate that inhibition of PKR activation does not affect
RSV replication. Furthermore, the decrease in RSV replication by 2-AP
appears to be mediated via a PKR-independent mechanism.
Discussion
Since RSV induces the expression and activation of PKR, we
hypothesized that activation of this dsRNA detector would mediate an
antiviral effect during RSV infection. Surprisingly, we found that
knockdown of PKR protein levels does not affect RSV replication.
However, treatment with the kinase inhibitor 2-AP (which inhibits
PKR) effectively blocks RSV replication regardless of PKR expression.
This PKR-independent effect on RSV replication suggests that
induction of other PKR-like kinases, which are 2-AP sensitive,
enhances RSV replication. The identity of such kinases is not known.
Our results are unexpected for two main reasons. First, PKR
initiates a cascade of events resulting in phosphorylation of eIF2α and
stress granule formation. These events are associated with stalled
translation initiation complexes, whichmight be expected to diminish
the capacity of host cells to support viral replication. Second,
induction of PKR is often associated with an antiviral state. For
example, both vesicular stomatitis virus and inﬂuenza virus replicate
to higher titers in PKR−/− mice in comparison to wild-type mice
(Balachandran et al., 2000). Similarly, PKR−/− mice succumb to
infection at a higher frequency when infected with Bunyamwera virus
in comparison to wild-type mice (Streitenfeld et al., 2003). However,
there are cases, in which PKR has a minimal effect on viral replication.
Severe acute respiratory syndrome coronavirus replication is
Fig. 6. Treatment with 2-AP inhibits RSV replication independent of PKR. (A) Wild-type HEp-2 cells or HEp-2 cells transduced with non-targeting shRNA (NonT) or PKR-speciﬁc
shRNA were pretreated with 10 mM 2-AP or vehicle. Cells were inoculated with RSV (MOI=0.1 pfu/cell) in the presence of 2-AP or vehicle for the indicated intervals. Titers of cell-
associated virus were determined for each time point by plaque assay. (B) Each cell type from (A) was pretreated with 10 mM 2-AP or vehicle and inoculated with RSV (MOI=1.0
pfu/cell) for 24 h in the presence of 2-AP or vehicle. Cell lysates were subjected to immunoblotting for RSV P protein and GAPDH. The relative amount of RSV P protein was quantiﬁed
for each cell type and compared to that in wild-type cells treated with vehicle. Error bars indicate standard deviations.
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oligomers speciﬁc for PKR mRNA (Krahling et al., 2009). Similarly,
treatment of cells with PKR siRNAs has little effect on adenovirus or
reovirus replication (Zhang and Samuel, 2007) or rotavirus protein
synthesis (Rojas et al., 2010). Rift Valley fever virus replication is not
altered in PKR−/− mouse embryo ﬁbroblast cells (Habjan et al.,
2009). However, PKR effects are not always antagonistic to viral
infection. Knockdown of PKR by shRNA results in signiﬁcantly
decreased HCV RNA levels in cells treated with exogenous interferon
and infected with HCV (Garaigorta and Chisari, 2009). Interestingly,
levels of other proteins involved in the antiviral response are
increased, suggesting that HCV induces PKR activation to inhibit
host translation and prevent the expression of interferon-stimulated
genes. We predicted a similar function for PKR during RSV infection
since previous reports have demonstrated that 2-AP treatment leads
to a dose-dependent increase in IFN-α production in RSV-infected
cells (Hornung et al., 2004).
Although RSV is a single-stranded RNA virus, it produces multiple
dsRNA intermediates during replication that are capable of activating
PKR. PKR activation is likely required for eIF2α phosphorylation and
subsequent stress granule formation during RSV infection (Lindquist
et al., 2010; Hanley et al., 2010). Other studies have reported that RSV
induces robust PKR activation during infection, but eIF2α phosphor-
ylation is limited (Groskreutz et al., 2010). Phosphorylation of eIF2α
may have been dampened by increased activity of protein phospha-
tase 2A (PP2A) during infection. In contrast, we observed extensive
eIF2α phosphorylation during RSV infection, predominantly in cells
that had been infected with RSV and in which stress granules had
formed (Fig. 1). Since phosphorylation of eIF2α frequently precedes
stress granule formation (Kedersha and Anderson, 2007), our results
are not surprising given the extensive stress granule formation
induced by RSV (Lindquist et al., 2010). It is possible that PP2A activity
is not sufﬁcient to reverse eIF2α phosphorylation in RSV-infected cells
that form stress granules. Further experiments are required to assess
PP2A activity in such cells.
Experiments using PKR-knockout mice show that RSV RNA levels
increase during infection, suggesting a classic role for PKR as anantiviral molecule. In PKR-knockout mice, RSV infection induces
lower levels of several cytokines, including TNF-α, IFN-β, and RANTES,
among others, in comparison to wild-type mice. These results, when
combinedwith histological analysis of mouse lung tissue, suggest that
functional PKR leads to enhanced pathogenesis in RSV-infected
animals (Minor et al., 2010).
Our previous data show that RSV replication is reduced in cells in
which stress granule formation is inhibited by knockdown of the
stress granule-related Ras-GAP SH3 domain-binding protein (G3BP)
(Lindquist et al., 2010). In the current study, we found that RSV
replication is unaffected in PKR-knockdown cells that similarly are
deﬁcient for stress granule formation. One possible explanation for
this discrepancy is that knockdown of G3BP has effects in addition to
inhibiting stress granule formation. Thus, viral replication might be
inhibited by an alternative effect of the G3BP knockdown. Another
possibility is that in PKR-knockdown cells, PKR signaling does not
occur, preventing the activation of intrinsic antiviral responses to the
virus. Thus, the potential pro-viral function for which stress granules
may normally be required would not be necessary, allowing the virus
to replicate efﬁciently.
The drug 2-AP has been cited as a speciﬁc inhibitor of PKR
activation (Hu and Conway, 1993; Loving et al., 2006; Silva et al.,
2004) and used in a number of studies examining the role of PKR
during viral infection. However, 2-AP also may inhibit activation of
tumor suppressor p53 during genotoxic stress (Huang et al., 2003),
interfere with cell cycle progression (Andreassen and Margolis,
1994), and inhibit mitogen-activated protein kinase activation
(Thorburn et al., 1994). Although PKR activation has been
implicated in each of these processes (Garcia et al., 2006), it is
possible that 2-AP inhibits multiple kinases. Our results demon-
strate that while 2-AP is efﬁcient at blocking PKR activation during
RSV infection, its inhibitory effect on RSV replication is PKR-
independent. Therefore, the reliability of 2-AP as a PKR-speciﬁc
inhibitor is suspect, given that the drug mediates non-PKR-
dependent effects. Deﬁning the other targets of 2-AP might lend
insight into the complex perturbations that occur in host gene
function during RSV infection.
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Cells
HEp-2 cells (ATCC CCL-23) were maintained in OPTI-MEM I
medium (Invitrogen) containing 5% (v/v) fetal calf serum (Sigma),
2 mM L-glutamine (Mediatech), 2.5 μg/mL amphotericin B (Media-
tech), 100 µg/mL streptomycin (Mediatech), and 100 I.U./mL
penicillin (Mediatech). L929 cells were grown in either suspension
or monolayer cultures in Joklik's modiﬁed Eagles minimal essential
medium (SMEM, Lonza) containing 5% (v/v) fetal bovine serum (FBS,
Invitrogen), 2 mM L-glutamine (Invitrogen), 100 U/mL of penicillin,
100 mg/mL of streptomycin (Invitrogen), and 250 μg/mL amphoter-
icin B (Sigma).
Viruses
A suspension of RSVwild-type strain A2prepared inHEp-2 cells (1×
106 pfu/mL)wasused to infectHEp-2 cellmonolayer cultures. Infectious
virus was adsorbed to the cells for 1 h in a 37 °C incubator in 5% CO2.
Following adsorption, the inoculum was removed and fresh medium
added. Cells then were incubated at 37 °C in 5% CO2 for the duration of
the infection period. Reovirus strain T1L is a laboratory stock.
Determination of viral titers
For RSV plaque assays, cell-associated virus was harvested at
indicated times by scraping infected HEp-2 cell culture monolayers
into 1.0 mL of medium. Virus then was released from harvested cells
as described (Utley et al., 2008). Viral titers were determined using
plaque assays as described (Murphy et al., 1990). For reovirus, titers
were determined by plaque assay using L929 cells. Reovirus-infected
HEp-2 cells were scraped into the medium, frozen at −80 °C and
thawed at room temperature twice prior to determination of viral
titer in the suspension by plaque assay (Virgin et al., 1988). Reovirus
yields were calculated according to the following formula: log10 yield
t=log10 (pfu/cell)t − log10 (pfu/cell)t0, where t is the time
postinfection and t0 is the time at inoculation after absorption.
2-Aminopurine (2-AP) treatment
We generated a 150 mM stock solution of 2-AP (Sigma A3509)
diluted in phosphate-buffered saline (PBS) and glacial acetic acid
(Fisher A-38-500). Glacial acetic acid was diluted at a ratio of 1:200 in
PBS. For each use, the solution was incubated at 60 °C for re-
suspension. HEp-2 cells were pretreated with 10 mM 2-AP diluted in
medium ormock-treatedwith vehicle (glacial acetic acid in PBS). Cells
then were infected with RSV in the presence of 10 mM 2-AP or vehicle
for 1 h. Following infection, the inoculum was removed and replaced
with fresh medium containing 10 mM 2-AP or vehicle and incubated
for the duration of infection.
Fixation and immunostaining
Cells were ﬁxedwith 3.7% (w/v) formaldehyde in PBS for 10min at
room temperature. Cells were permeabilized with 0.2% (w/v) Triton
X-100 and 3.7% paraformaldehyde in PBS for 10 min at room
temperature. Following ﬁxation, cells were blocked in 5% (w/v) BSA
in PBS for 1 h followed by addition of primary antibody for 1 h. Cells
then were washed three times in PBS and species-speciﬁc IgG Alexa
Fluor (Molecular Probes) was added at a dilution of 1:1000 in block
solution for detection of primary antibodies. Cells were washed 3
times in PBS and ﬁxed on glass slides using Prolong Antifade kit
(Molecular Probes). Images were obtained using a Zeiss inverted
LSM510 confocal microscope equipped with a 40× Plan-Neoﬂuar oil
objective lens.A polyclonal anti-TIA-1 (sc-1751) antibody was obtained from
Santa Cruz and used for immunostaining. Monoclonal anti-phosphor-
ylated eIF2α (1090-1) and anti-PKR (1511-1) antibodies were
obtained from Epitomics. An anti-RSV F protein humanized mouse
monoclonal antibody (palivizumab; MedImmune) was used to
identify RSV F protein. Anti-RSV P protein (clone 3_5) monoclonal
antibody was a kind gift of Ewa Bjorling and Earling Norrby.
shRNA reagents
Lentiviral shRNA particles were obtained from Dharmacon for
human GAPDH (S-001000-01), a non-targeting control (S-005000-
01), and a set of three PKR SMARTvector shRNA constructs (SK-
003527-00-10). HEp-2 cells were plated in 96-well plates and
transduced with individual lentiviral constructs according to the
manufacturer's protocol. For selection of each target, cells containing
integrated lentivirus sequences were selected using puromycin (5 μg/
mL) diluted in medium. Medium containing puromycin was replaced
every 3 days until resistant colonies were observed.
Immunoblotting
HEp-2 cells were grown in 6-well plates and harvested for protein.
Cells were lysed using lysis buffer (50 mM Tris–HCl, 150 mM NaCl, 1%
Triton X-100, pH 8.0) containing 0.5% (v/v) of protease inhibitor
cocktail (Sigma) and 1.0% (v/v) of phosphatase inhibitors (Sigma).
Lysates were separated in 4–12% NuPAGE Bis–Tris gels (Invitrogen)
and transferred to nitrocellulose membranes using an iBlot dry-
blotting system (Invitrogen). Membranes were blocked for 1 h using
Odyssey blocking buffer (Li-Cor) diluted 1:1 in PBS. Primary
antibodies were diluted in blocking buffer and incubated overnight
at 4 °C. Membranes then were washed four times in Tris buffered
saline with 0.2% Tween (TBST) for 5 min each. Li-Cor IRDye 680CW or
IRDye 800CW secondary antibodies were diluted 1:5000 in blocking
buffer and added to eachmembrane for 1 h. Membranes were washed
four times in TBST. Bands were imaged and quantiﬁed using the
Odyssey Infrared Imaging System. Total PKR or phosphorylated PKR
were detected using monoclonal antibodies from Epitomics (1511-1
and 2283-1, respectively). GAPDH was detected using a monoclonal
antibody from Millipore (MAB374).
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